Company Filing History:
Years Active: 2016-2019
Title: Yulin Lam: Innovator in Anti-Cancer and Anti-Inflammatory Research
Introduction
Yulin Lam is a prominent inventor based in Singapore, known for his contributions to the field of anti-cancer and anti-inflammatory drug development. With a total of 2 patents, he has made significant strides in creating innovative solutions for pressing health issues.
Latest Patents
Yulin Lam's latest patents include groundbreaking research on the use of a polyenylpyrrole derivative in the preparation of anti-oral cancer drugs. This invention discloses the synthesis of a polyenylpyrrole derivative using polyvinylpyrrole, auxarconjugatin A, and 12E-isorumbrin, which has shown to inhibit cell proliferation, migration, tumor sphere formation abilities, and xenograft tumorigenicity of oral cancer cells. Additionally, he has developed a method for treating inflammation that involves administering a therapeutically effective amount of polyenylpyrrole derivatives or their pharmaceutically acceptable salts.
Career Highlights
Throughout his career, Yulin Lam has worked with esteemed institutions such as Tzu Chi University and Wellhead Biological Technology Corporation. His work has focused on advancing medical research and developing effective treatments for cancer and inflammation.
Collaborations
Yulin Lam has collaborated with notable colleagues, including Kuo-Feng Hua and Jeng-Woei Lee, to further enhance his research and innovations in the field.
Conclusion
Yulin Lam's contributions to medical research through his patents and collaborations highlight his commitment to improving health outcomes. His innovative approaches in drug development continue to pave the way for future advancements in treating cancer and inflammation.